USFDA approves Sun Pharmaceutical's ANDA to market Rilutek tablets
Links shared publicly online about this topic.
- 839total visits
USFDA approves Sun Pharmaceutical's ANDA to market Rilutek tablets
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted a tentative approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Sanofi Aventis's Rilutek® tablets 50 mg.
View full resource at news-medical.net
Tags: Drug, Pharma, Sanofi-Aventis
Most Recently Shared on September 29, 2010 at 4:36 am By:
USFDA approves Sun Pharmaceutical's ANDA to market Rilutek tablets: Sun Pharmaceutical Industries Ltd. announced t... http://bit.ly/97Wy06
USFDA grants Sun Pharma tentative approval for generic Stalevo ANDA
news-medical.net — “Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary a tentative approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Orion's Stalevo® tablets.” View full resource at news-medical.net
Most Recently Shared on October 1, 2010 at 9:10 pm By:
Parkinson's Disease: USFDA grants Sun Pharma tentative approval for generic Stalevo ANDA: Sun Pharmaceutical Indus... http://bit.ly/9yLRas
Advertisement
